Fernanda Tavares Da Silva

2.9k total citations · 2 hit papers
39 papers, 1.7k citations indexed

About

Fernanda Tavares Da Silva is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Fernanda Tavares Da Silva has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 10 papers in Health and 9 papers in Infectious Diseases. Recurrent topics in Fernanda Tavares Da Silva's work include Vaccine Coverage and Hesitancy (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Herpesvirus Infections and Treatments (9 papers). Fernanda Tavares Da Silva is often cited by papers focused on Vaccine Coverage and Hesitancy (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Herpesvirus Infections and Treatments (9 papers). Fernanda Tavares Da Silva collaborates with scholars based in Belgium, United States and United Kingdom. Fernanda Tavares Da Silva's co-authors include Nathalie Garçon, Alberta Di Pasquale, Scott Preiss, Caroline Hervé, Béatrice Laupèze, Arnaud M. Didierlaurent, Giuseppe Del Giudice, Vincent Bauchau, Lawrence Segal and Marcelle Van Mechelen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Archives of Biochemistry and Biophysics and Vaccine.

In The Last Decade

Fernanda Tavares Da Silva

39 papers receiving 1.7k citations

Hit Papers

Vaccine Adjuvants: from 1920 to 2015 and Beyond 2015 2026 2018 2022 2015 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vaccine Adjuvants: from 1920 to 2015 and Beyond
    2015 466 citations Alberta Di Pasquale, Fernanda Tavares Da Silva et al. profile →
  2. The how’s and what’s of vaccine reactogenicity
    2019 328 citations Caroline Hervé, Béatrice Laupèze et al. npj Vaccines profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernanda Tavares Da Silva Belgium 18 672 553 529 310 299 39 1.7k
Alberta Di Pasquale Belgium 15 520 0.8× 661 1.2× 450 0.9× 386 1.2× 311 1.0× 25 1.5k
Hayley A. Gans United States 17 1.1k 1.6× 593 1.1× 520 1.0× 121 0.4× 386 1.3× 52 1.7k
Santosh Dhakal United States 24 447 0.7× 497 0.9× 818 1.5× 314 1.0× 107 0.4× 83 1.9k
Philip Tarr Switzerland 29 765 1.1× 282 0.5× 1.0k 1.9× 214 0.7× 258 0.9× 110 2.9k
Renata J.M. Engler United States 21 439 0.7× 303 0.5× 779 1.5× 283 0.9× 172 0.6× 72 2.2k
Jingxin Li China 25 437 0.7× 268 0.5× 2.0k 3.8× 405 1.3× 454 1.5× 110 2.9k
Hana M. El Sahly United States 23 930 1.4× 323 0.6× 981 1.9× 386 1.2× 83 0.3× 81 1.8k
Kirsten P. Perrett Australia 24 986 1.5× 306 0.6× 321 0.6× 139 0.4× 431 1.4× 123 2.4k
Édouard Tuaillon France 30 1.3k 2.0× 410 0.7× 1.3k 2.4× 317 1.0× 55 0.2× 147 2.9k
David R. Martinez United States 20 348 0.5× 320 0.6× 1.1k 2.0× 282 0.9× 86 0.3× 62 1.8k

Countries citing papers authored by Fernanda Tavares Da Silva

Since Specialization
Citations

This map shows the geographic impact of Fernanda Tavares Da Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Tavares Da Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Tavares Da Silva more than expected).

Fields of papers citing papers by Fernanda Tavares Da Silva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Tavares Da Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Tavares Da Silva. The network helps show where Fernanda Tavares Da Silva may publish in the future.

Co-authorship network of co-authors of Fernanda Tavares Da Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Tavares Da Silva. A scholar is included among the top collaborators of Fernanda Tavares Da Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Tavares Da Silva. Fernanda Tavares Da Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silva, Fernanda Tavares Da. (2025). The Impact of Normothermic Regional Perfusion in Kidney Transplantation: A Systematic Review and Meta-analysis. American Journal of Transplantation. 25(1). S38–S38. 1 indexed citations
2.
Mora, M., et al.. (2024). Safety and efficacy of direct oral anticoagulants in kidney transplant recipients: A systematic review and meta-analysis. Transplantation Reviews. 39(1). 100899–100899. 1 indexed citations
3.
Cheuvart, Brigitte, et al.. (2023). Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials. Expert Review of Vaccines. 22(1). 849–859. 1 indexed citations
4.
Sullivan, Keith M., Francis A. Farraye, Kevin Winthrop, et al.. (2022). Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine. 41(1). 36–48. 16 indexed citations
5.
6.
7.
Eckert, Linda O., Christine E. Jones, Alisa Kachikis, et al.. (2020). Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women. Vaccine. 38(29). 4542–4547. 1 indexed citations
8.
Laupèze, Béatrice, Caroline Hervé, Alberta Di Pasquale, & Fernanda Tavares Da Silva. (2019). Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. Vaccine. 37(38). 5670–5680. 40 indexed citations
9.
Burny, Wivine, Arnaud Marchant, Caroline Hervé, et al.. (2019). Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans. Vaccine. 37(14). 2004–2015. 51 indexed citations
10.
Silva, Fernanda Tavares Da, Caroline Hervé, Marta López‐Fauqued, et al.. (2019). Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine. Vaccine. 38(18). 3489–3500. 31 indexed citations
11.
Hervé, Caroline, Béatrice Laupèze, Giuseppe Del Giudice, Arnaud M. Didierlaurent, & Fernanda Tavares Da Silva. (2019). The how’s and what’s of vaccine reactogenicity. npj Vaccines. 4(1). 39–39. 328 indexed citations breakdown →
12.
Lecrenier, Nicolas, Rómulo E. Colindres, Desmond Curran, et al.. (2018). Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Review of Vaccines. 17(7). 619–634. 76 indexed citations
13.
Giordano, Giulia Maria, Éric Destexhe, Dinesh Stanislaus, et al.. (2017). Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo-fetal and post-natal developmental toxicity studies in rats and rabbits. Reproductive Toxicology. 75. 110–120. 3 indexed citations
14.
Rouse, Caroline E., Linda O. Eckert, Emily Fay, et al.. (2017). Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 35(48). 6563–6574. 35 indexed citations
15.
Pasquale, Alberta Di, Paolo Bonanni, Nathalie Garçon, et al.. (2016). Vaccine safety evaluation: Practical aspects in assessing benefits and risks. Vaccine. 34(52). 6672–6680. 85 indexed citations
16.
Silva, Fernanda Tavares Da, Bernard Gonik, Mark McMillan, et al.. (2016). Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 34(49). 6057–6068. 114 indexed citations
17.
Taylor, Sylvia, Frank Struyf, Fernanda Tavares Da Silva, et al.. (2014). Strategies for continuous evaluation of the benefit–risk profile of HPV-16/18-AS04-adjuvanted vaccine. Expert Review of Vaccines. 13(11). 1297–1306. 8 indexed citations
18.
Nazareth, Irwin, Fernanda Tavares Da Silva, Dominique Rosillon, François Haguinet, & Vincent Bauchau. (2013). Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study. BMJ Open. 3(2). e001912–e001912. 12 indexed citations
19.
Silva, Fernanda Tavares Da, Filip De Keyser, Paul‐Henri Lambert, et al.. (2013). Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines. Vaccine. 31(14). 1870–1876. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberta Di Pasquale Breakdown of academic impact, for papers by Hayley A. Gans Breakdown of academic impact, for papers by Santosh Dhakal Breakdown of academic impact, for papers by Philip Tarr Breakdown of academic impact, for papers by Renata J.M. Engler Breakdown of academic impact, for papers by Jingxin Li Breakdown of academic impact, for papers by Hana M. El Sahly Breakdown of academic impact, for papers by Kirsten P. Perrett Breakdown of academic impact, for papers by Édouard Tuaillon Breakdown of academic impact, for papers by David R. Martinez
Rankless by CCL
2026